- Home
- ALVO vs VIRT Comparison
ALVO vs VIRT Comparison
Compare ALVO & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALVO | VIRT |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 2.8B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | ALVO | VIRT |
|---|---|---|
| Price | $5.54 | $33.68 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 7 |
| Target Price | $9.25 | ★ $41.43 |
| AVG Volume (30 Days) | 544.6K | ★ 724.0K |
| Earning Date | 11-12-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 2.83% |
| EPS Growth | N/A | ★ 132.69 |
| EPS | 0.24 | ★ 4.62 |
| Revenue | $573,350,000.00 | ★ $2,694,104,000.00 |
| Revenue This Year | $20.97 | N/A |
| Revenue Next Year | $43.04 | N/A |
| P/E Ratio | $23.19 | ★ $7.34 |
| Revenue Growth | ★ 45.55 | 41.05 |
| 52 Week Low | $4.32 | $31.89 |
| 52 Week High | $13.70 | $45.77 |
Technical Indicators
Market Signals| Indicator | ALVO | VIRT |
|---|---|---|
| Relative Strength Index (RSI) | 48.24 | 40.56 |
| Support Level | $5.23 | $34.81 |
| Resistance Level | $5.85 | $36.25 |
| Average True Range (ATR) | 0.32 | 0.86 |
| MACD | 0.17 | -0.09 |
| Stochastic Oscillator | 80.07 | 9.19 |
Price Performance
Historical ComparisonAbout ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
About VIRT Virtu Financial Inc.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.